I]SST-28 as radioligand. Internalization into AR42J cells was studied in dual-tracer studies with [
125 I]TOC as internal reference. Biodistribution was investigated using AR42J tumor-bearing CD1 mice, and specificity of tracer uptake was confirmed in competition studies by coinjection of 0.8 mg TOC/kg.
Results: Sst 2 affinities (IC 50 ) of [
nat Ga]HA-DOTATATE (1.4 ± 0.8 nM, logP: −3.16) and [ nat Ga]DOTATATE (1.2 ± 0.6 nM, logP: −3.69) were nearly identical. Both compounds displayed IC 50 > 1 μM for sst 1, 3, 4 , while sst 5 affinity was markedly increased for nat Ga-HA-DOTATATE (102 ± 65 nM vs >1 μM for nat Ga-DOTATATE 3 -octreotide) has also entered the clinical arena [4] . Due to its high affinity to sst 2 , sst 3 and sst 5 , significantly more and smaller lesions are detected using [ 68 Ga]DOTANOC compared to the sst 2 -selective highaffinity ligand [ 68 Ga]DOTATATE, suggesting it to be the preferred agent for the imaging application [5] .
However, in the context of sst-targeted endoradiotherapy using the respective 177 Figure 1 ). In the first in vitro studies, Ga-HA-DOTATATE had shown unchangedly high sst 2 affinity compared to Ga-DOTATATE and increased affinity to sst 5 [7] . Given that the physicochemical properties of [ 68 )-somatostatin-28 were supplied by Bachem (Heidelberg, Germany). All other organic reagents were purchased from VWR (Darmstadt, Germany) or Sigma-Aldrich or Fluka (Munich, Germany). Solvents were used without further purification. Solid phase peptide synthesis was carried out manually using an Intelli-Mixer syringe shaker (Neolab, Heidelberg, Germany).
Analytic RP-HPLC was performed on a Nucleosil 100 C18 (5 μm, 125 × 4.0 mm internal diameter (i. (CS GmbH, Langerwehe, Germany) using a Sykam gradient HPLC System (Sykam, Fürstenfeldbruck, Germany).
The peptides were eluted applying various gradients of 0.1% TFA (trifluoroacetic acid) in H 2 O (solvent A) and 0.1% TFA in acetonitrile (solvent B) over 15 min at a constant flow of 1 mL/min. Preparative RP-HPLC was performed on the same HPLC system using a Multospher 100 RP 18-5 (250 × 10 mm i.d.) column (CS GmbH, Langerwehe, Germany) at a constant flow of 5 mL/min. UV detection was performed at 220 nm using a 206 PHD UV-vis detector (Linear™ Instruments Corporation, Reno, NV, USA). For radioactivity measurement, the outlet of the UV photometer was connected to a NaI(Tl) welltype scintillation counter from EG&G Ortec (München, Germany). Radio-TLC was carried out using a Varian silica impregnated ITLC chromatography paper (Varian Inc., Palo Alto, CA, USA) and a 1:1 (v/v) mixture of 1 M aq. NH 4 OAc and MeOH as mobile phase. TLC strips were analyzed using a miniGita TLC analyzer (Raytest, Straubenhardt, Germany).
Mass spectra were recorded on the LC-MS system LCQ from Finnigan (Bremen, Germany) using a Hewlett Packard series 1100 HPLC system (Agilent Technologies Inc., Santa Clara, CA, USA).
DOTATATE and HA-DOTATATE
DOTATATE and HA-DOTATATE were synthesized according to a previously published protocol [10] 
Ga labeling
68 Ga-labeling of DOTATATE and HA-DOTATATE (5 nmol) was carried out in a fully automated, GMPcompliant procedure using a Scintomics Gallelut + module (Scintomics, Fürstenfeldbruck, Germany) [11, 12] . Briefly, a 68 Ge/ 68 Ga generator with SnO 2 matrix (iTHEMBA LABS, South Africa) was eluted with 1.0 M aq. HCl, and in order to minimize the reaction volume, a fraction of 1.25 mL containing approx. 80% of the eluted 68 Ga activity was used for the labeling reaction. HEPES (3.7 M, 800 μL) was used to adjust the pH of the reaction mixture to pH 3. After heating to 95°C for 5 min, the reaction mixture was passed through a SPE cartridge (SepPak® C18, Waters, Eschborn, Germany). The cartridge was washed with water and the 68 Ga-labeled peptides were eluted in a small volume of ethanol. For in vitro studies, the product fraction was diluted with PBS and used as such for further dilutions. For the in vivo biodistribution studies, the ethanol content of the product solution was evaporated in vacuo.
For quality control, radio-TLC was carried out using a Varian silica impregnated glass fiber TLC chromatography paper (Agilent Technologies, Waldbronn, Germany) and a 1:1 (v/v) mixture of 1 M aq. NH 4 OAc and MeOH as mobile phase. TLC strips were analyzed using a BioScan TLC analyzer (BioScan, Tucson, AZ, USA). Lu as calculated from the specific activity at the day of the experiment) was added. The mixture was diluted with NH 4 OAc (0.1 M) to a total volume of 200 μL (pH = 5 in the final reaction mixture) and heated to 95°C for 30 min. Upon cooling to room temperature and determination of the labeling yield using Radio-TLC, the labeling mixture was directly diluted with assay buffer to a final peptide concentration of 20 nM and used as such for the subsequent in vitro studies. (18 to 20 MBq, Hartmann Analytik, Braunschweig, Germany), the reaction vessel was briefly vortexed, and the labeling reaction was allowed to proceed for 15 min at RT. The peptide solution was then removed from the insoluble oxidizing agent. Separation of the radioiodinated peptides from unlabeled precursor was achieved using gradient RP-HPLC (gradient: 22% to 37% solvent B within 20 min, flow: 1 mL/min). For the subsequent in vitro studies, the respective HPLC product fraction was used as such and diluted to the required concentration using assay buffer.
Determination of lipophilicity

Lipophilicities of [
68 Ga]DOTATATE/HA-DOTATATE and [
177 Lu]DOTATATE/HA-DOTATATE were determined via a modified shake flask method as described previously [13] .
In vitro studies Determination of IC 50 using cell membranes Cell membrane preparations of cells expressing the human sst [1] [2] [3] [4] [5] were obtained from Millipore (Schwalbach, Germany) and PerkinElmer (Rodgau, Germany). Competition binding studies were performed in close analogy to the manufacturer's protocol. Briefly, solutions of unlabeled competitor ( nat Ga-DOTATATE, nat Lu-DOTATATE, were added. Then, 5 μg of cell membrane in 80 μL of binding buffer were added per well and incubated for 60 min at RT. The final radioligand concentration in the incubation mixture was 0.42 nM. Membranes were then aspired onto a glass fiber filtermat (Printed Filtermat B, Wallach, Turku, Finland), which had been preconditioned with 0.33% polyethylenimine for 30 min and then washed five times with 300 μL (per well) of wash buffer (50 mM HEPES, 500 mM NaCl, 0.1% BSA, buffered to pH 7.4 using 1 N NaOH), using a Mach II M Harvester 96 (Tomtec CE, Etten-Leur, The Netherlands). Membranes were washed ten times with 150 μL (per well) of wash buffer. The filtermat was then cut into squares containing the membrane from the respective wells, and membrane bound activity was counted in a γ-counter. IC 50 values were calculated from bound activity [cpm] using PRISM 6 software (Graph Pad Software, San Diego, CA, USA).
Dual-tracer internalization studies using AR42J cells AR42J cells (rat pancreatic adenocarcinoma) were obtained from ECACC (European Collection of Cell Cultures, Salisbury, UK). Cells were maintained in RPMI 1640 (Biochrom, Berlin, Germany) supplemented with 10% FCS (Seromed-Biochrom, Berlin, Germany) and 2 mM L-glutamine (Gibco BRL Life Technologies, Karlsruhe, Germany). Cells were maintained at 37°C in a 5% CO 2 /humidified air atmosphere. In the assay medium used for internalization studies, FCS was replaced by 5% BSA (Sigma-Aldrich, Munich, Germany).
To avoid the influence of inter-experimental variations in cell count and cell viability on absolute internalization data, all internalization experiments were performed as dual-tracer studies using [ 125 I]TOC as an internal reference. Experiments were carried out as previously described with minor modifications [14] . Briefly, after preconditioning of the cells (approx. 200,000 cells/well) with 200 μL of assay medium for a minimum of 15 min, 25 μL (per well) of either assay medium (total internalization) or 50 μM unlabeled TOC (nonspecific internalization) were added, followed by the addition of 25 μL of assay medium containing a mixture of the respective 68 Lu) and 0.1 nM, respectively, and were calculated based on the specific activities of the radioligands used. After incubation at 37°C for different time points up to 60 min, the incubation medium was removed, and cells were rinsed with 250 μL of unsupplemented medium. The combined medium fractions represent the amount of free radioligand. Receptor bound (acid releasable) radioactivity was then removed using 2 × 250 μL of ice cold acid wash buffer (0.02 M NaOAc buffered with AcOH to pH = 5). The internalized activity was released by incubation with 250 μL of 1 N NaOH, transferred to vials and combined with 250 μL of PBS used for rinsing the wells. Quantification of the amount of free, acid-releasable, and internalized activity was performed in a γ-counter. Data for total internalized ligand (mean ± SD) were corrected by non-specific internalization (mean ± SD) at the respective time point using Excel considering the laws of error propagation.
Biodistribution experiments
All animal experiments were performed in accord with current animal welfare regulations in Germany (approval #55.2-1-54-2532-71-13).
AR42J tumor model
To establish tumor growth, AR42J cells were detached from the surface of the culture flasks using 1 mM EDTA in PBS, centrifuged, and resuspended in serum-free culture medium. Concentration of the cell suspension was 2.5 to 5 × 10 6 cells/100 μL. Nude mice (CD-1 nu/nu, female, 6 to 8 weeks, from Charles River WIGA GmbH, Sulzfeld, Germany) were injected with 100 μL of the cell suspension subcutaneously into the flank. Ten days after tumor transplantation, all mice showed solid palpable tumor masses (tumor weight 20 to 90 mg) and were used for the experiments.
Biodistribution studies
The 68 Ga-labeled peptides, 1.1 to 1.7 MBq (depending on the respective specific activity of the radiotracer; the peptide amount per mouse was kept constant at 25 pmol) in 100 μL of PBS (pH 7.4), were injected i.v. into the tail vein of nude mice bearing an AR42J tumor. For competition studies, 20 μg TOC (0.8 mg/kg) were coinjected with the radioligands. The animals (groups of 4 to 5) were sacrificed 1 h post injection and the organs of interest were dissected. The radioactivity was measured in weighted tissue samples using a γ-counter. Data are given in %iD/g and are means ± SD. ]-somatostatin 28 in radiochemical purities >99% and yields of 68 ± 4% and 54 ± 5% after HPLC purification, respectively. Since the HPLC conditions applied allowed very efficient separation of the radioiodinated products from the unlabeled precursors (Δt R ≥ 5 min) and no co-eluting carrier peak was observed in the labeled peptide peak in the quality control UV chromatograms, the specific activity of 68 Ga-DOTA complexes [15] .
Results and discussion
Radiolabeling
In vitro studies IC 50 studies using membrane preparations (sst [1] [2] [3] [4] [5] Affinities (IC 50 in nM) of the respective nat Ga and nat Lu complexes of DOTATATE and HA-DOTATATE as well as nat Y-HA-DOTATATE for hsst [1] [2] [3] [4] [5] are summarized in Table 2 . Data were determined using membrane preparations of CHO cells stably transfected with the respective sst subtype. Since in our earlier studies [7, 8] only preliminary results (n = 2 experiments) had been published, further experiments were performed to validate these data.
In comparison to the previously published affinities, absolute IC 50 values are slightly increased when averaging Partition coefficients (logP O/PBS ) of the radioligands between PBS (pH 7.4) and n-octanol were determined using a shake flask method (n = 6) [13] .
the full data set. However, it was confirmed that nat Ga Ga-DOTATATE and nat Y-DOTATATE using receptor autoradiography (0.20 ± 0.04 and 1.6 ± 0.4 nM, respectively) [16] . The reduced 'sensitivity' of our experimental setup might also explain why nat Ga-DOTATATE and nat Lu-DOTATATE showed virtually no hsst 4 and hsst 5 affinity in this study, while affinities in the range of 200 to 500 nM were observed in the autoradiography assay [16] .
In this context, the confirmed substantially enhanced hsst 5 affinities of nat Ga-/ nat Lu-HA-DOTATATE compared to the respective DOTATATE analogs, which represents the rationale for terming these compounds 'high-affinity DOTATATE' (HA-DOTATATE), are even more noteworthy.
Unfortunately, at the time of the second series of experiments, the hsst 3 ChemiSCREEN® membrane (Millipore, Schwalbach, Germany) preparation was not available from the manufacturer anymore, and therefore, the data set for this sst subtype could not be completed under the original experimental conditions. To nevertheless be able to fully evaluate the sst subtype specificities of nat Ga-/ nat Lu-HA-DOTATATE, membrane preparations from CHO-K1 cells transfected with hsst [2] [3] [4] [5] were purchased from an alternative supplier (PerkinElmer), and experiments were repeated under experimental conditions identical to the previous experiments in triplicate. Unexpectedly, absolute IC 50 values were found to be generally increased by a factor of 2.5 to 3.5 compared to the values obtained using the ChemiSCREEN® membranes, independently of the hsst subtype assayed. For example, hsst 2A affinities determined for nat Ga-and nat Lu-DOTATATE and nat Ga-, nat Lu-, and nat Y-HA-DOTATATE in this assay were 2.9 ± 0.6, 7.3 ± 2.6, 3.8 ± 1.0, 6.6 ± 1.4, and 6.7 ± 0.1 nM, respectively. Despite the upward shift in absolute IC 50 values, these data very well reflect the relative affinities determined using the ChemiSCREEN® membranes. The same was also observed for the data obtained for hsst [3] [4] [5] .
Thus, despite the limited numerical compatibility of the two separate data sets, both satisfactorily reflect the important differences in the sst subtype affinity profiles of the different DOTATATE and HA-DOTATATE analogs, namely the substantially enhanced hsst 5 (and hsst 3 ) affinities of the HA-DOTATATE compounds. Therefore, the data in Table 2 were deemed satisfactorily significant to serve as representative values.
Dual-tracer internalization studies
Comparative internalization studies for [ Ga ]DOTATATE was unexpected, considering their identical sst 2 affinities. However, it has already been demonstrated that internalization efficiency of TATE analogs does not necessarily correlate with sst 2 affinity [14, 19] . Furthermore, the fact that the sst 2 affinities were determined in membrane preparations expressing the human receptor, while internalization studies were carried out using rat-sst 2 -expressing AR42J cells, might also contribute to the discrepancies observed between binding and internalization data (Figure 2 ). For control experiments, animals (n = 5 per group) were injected with tracer only. For competition experiments, 20 μg/mouse of unlabeled TOC were coinjected with the respective radioligand (n = 3 per group). Data are expressed as %ID/g (mean ± SD).
Biodistribution studies
tumor-bearing mice fully mirror the observations made in our previously published comparative PET imaging and dosimetry studies in patients [7] [8] [9] . Due to its enhanced internalization efficiency, [ 68 Ga]HA-DOTATATE shows high uptake in sstexpressing mouse tissues such as the stomach, adrenals, pancreas, and the AR42J tumor xenografts (increased by a factor of 1.4 to 2 compared to [ 68 Ga]DOTATATE) [21] . Sst specificity of tracer uptake in these organs was confirmed in a competition study by coinjection of an excess of unlabeled TOC (Table 3 and Figure 3 ). Interestingly, sstmediated tracer accumulation was also observed in the lung, spleen, and intestines both for [
68 Ga]DOTATATE and [
68 Ga]HA-DOTATATE, underlining the suitability of both radioligands for the sensitive in vivo detection of even low sst expression levels. Of the two compounds investigated, [
68 Ga]HA-DOTATATE showed a slightly higher proportion of non-blockable tissue uptake in the competition study, reflecting the higher blood activity concentration of this compound under the experimental conditions.
Again, the preclinical mouse data obtained in this study parallel the findings from our human PET studies, where [ 
